Reckitt, Watson Drop Patent In Suit Over Mucinex ANDA
Reckitt Benckiser Inc. and Watson Pharmaceuticals Inc. have agreed to drop one of the two patents asserted in their dispute over Watson's attempt to make a generic version of the blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article